DSM-5 and RDoC: Progress in psychiatry research?

Nature Reviews Neuroscience

Volumn 14, Issue 11, 2013, Pages 810-814

  Casey, B J ^a   Craddock, Nick ^b   Cuthbert, Bruce N ^c   Hyman, Steven E ^d   Lee, Francis S ^a   Ressler, Kerry J ^e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BRAIN DEPTH STIMULATION; CEREBROSPINAL FLUID; DSM-5; DSM-IV; GENETICS; HUMAN; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MENTAL DISEASE; NARCOLEPSY; NEUROSCIENCE; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHIATRY; REVIEW; TREATMENT RESISTANT DEPRESSION;

BIOMEDICAL RESEARCH; BRAIN; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MENTAL DISORDERS; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); NEUROPSYCHOLOGICAL TESTS; PSYCHIATRY; UNITED STATES;

EID: 84886043405     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn3621     Document Type: Review

References (6)

1. Kupfer, D. J., Kuhl, E. A. & Regier, D. A. DSM-5 - the future arrived. JAMA 309, 1691-2169 (2013).
2. Kupfer, D. J. & Regier, D. A. Neuroscience, clinical evidence, and the future of psychiatric classification in DSM-5. Am. J. Psychiatry 168, 672-674 (2011).
3. US National Institute of Mental Health. Strategy 1.4 of the 2008 NIMH Strategic Plan. Sec1:9. nimh.nih.gov [online], http://www.nimh.nih.gov/about/ strategic-planning-reports/nimh-strategic-plan-2008.pdf (2008).
4. Cuthbert, B. N. & Insel, T. R. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 11, 126 (2013).
5. Soliman, F. et al. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 327, 863-866 (2010).
6. Felmingham, K. L., Dobson-Stone, C., Schofield, P. R., Quirk, G. J. & Bryant, R. A. The brain-derived neurotrophic factor Val66Met polymorphism predicts response to exposure therapy in posttraumatic stress disorder. Biol. Psychiatry 73, 1059-1063 (2013).